Benoit Pilmis

Hélène Coignard-Biehler

Marc Lecuit

Olivier Hermine

Olivier Lortholary

Philippe Touraine

Vincent Jullien

ABSTRACT
          
            Iatrogenic Cushing's syndrome is an undesirable outcome of glucocorticoids treatment. It can be increased by pharmacologic interactions. Glucocorticoid therapy, given in association with ritonavir, and some azole treatments are causes of iatrogenic Cushing's syndrome. We present a patient with common-variable immunodeficiency who received 7 years of itraconazole therapy for bronchial colonization with
            Aspergillus
            in combination with inhaled fluticasone without any Cushingoid symptoms. After a switch to posaconazole, the patient developed Cushingoid symptoms.
          </jats:p

Crossref

Antimicrobial Agents and Chemotherapy

Iatrogenic Cushing's Syndrome Induced by Posaconazole

Iatrogenic Cushing's Syndrome Induced by Posaconazole

Abstract

Similar works

Full text

Available Versions

Crossref